Detalles de la búsqueda
1.
Cell cycle independent role of cyclin D3 in host restriction of SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-491022
2.
Extended in vitro inactivation of SARS-CoV-2 by titanium dioxide surface coating
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-415018
3.
Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20100990
4.
Transmission of B.1.617.2 Delta Variant between vaccinated healthcare workers in Delhi, India
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21266406
5.
SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-491004
6.
Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-422555
7.
Age-related heterogeneity in Neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251054
8.
Combined point of care nucleic acid and antibody testing for SARS-CoV-2: a prospective cohort study in suspected moderate to severe COVID-19 disease.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20133157
9.
Antibody responses to AZD1222 vaccination in West Africa
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22274668
10.
The impact of Spike mutations on SARS-CoV-2 neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-426849
11.
The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21252268
12.
Rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical trial and implementation study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20114520
13.
Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21264054
14.
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-481609
15.
Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249801
16.
Early immune pathology and persistent dysregulation characterise severe COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20248765
17.
Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20241927
18.
Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22281024
19.
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21258076
20.
Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-476382